FDA Drug information
Abilify MyCite
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Abilify MyCite ARIPIPRAZOLE 10 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 10 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 15 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 15 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 15 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 2 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 2 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 20 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 20 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 30 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 30 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 5 mg/1 Otsuka America Pharmaceutical, Inc.
- Abilify MyCite ARIPIPRAZOLE 5 mg/1 Otsuka America Pharmaceutical, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.